Ophthalmology department, Benha University, EGYPT
Banhā, 13511, Egypt
NCT Number: NCT05249413
Post-operative infectious endophthalmitis is devastating condition that causes a diffuse intraocular inflammation and may lead to blindness. Acute post-operative endophthalmitis usually presented within 6 weeks of intraocular procedure and diagnosis is confirmed by clinical examination and by the aid of B-scan ultrasonography.
Looking for future studies?
Notify Me3 year–80 year
All sexes
Observational
Banhā, 13511, Egypt
There is no consensus regarding the timing of vitrectomy in cases with endophthalmitis after cataract surgery. The Endophthalmitis Vitrectomy Study concluded that vitrectomy should be preserved for cases with only light perception. The advances in posterior segment machines and small gauge cannulas decrease the incidence of intra-operative complications and encourage for early intervention in cases with endophthalmitis after primary cataract surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
pars-plana vitrectomy for management of acute post-operative endophthalmitis.
Time frame: Baseline and 3 months after intervention.
Changes in visual acuity from baseline and after early vitrectomy operation.
Time frame: Baseline and 3 months after intervention.
Other factors that may influence the final visual outcome in cases with endophthalmitis as (intraocular tamponade, posterior vitreous detachment, systemic condition and virulence of causative organism)
Benha University
Other
Outcomes of Early Vitrectomy for Endophthalmitis After Cataract Surgery in Delta Population, Egypt, 2015-2020.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04568213
Cataract, Endophthalmitis
Loma Linda, California, United States
View Trial DetailsNCT03363295
Cataract, Endophthalmitis
Campinas, São Paulo, Brazil
View Trial DetailsNCT00730938
Cataract, Endophthalmitis
Kikuyu, Kenya
View Trial DetailsNCT07717944
Endophthalmitis, Endophthalmitis Postoperative
Banhā, Benha, Egypt
View Trial Details